Cigna, HopeLab Turn to Mobile to Support Medical Professionals, Patients

As our sister site mHealthWatch recently reported,  the team at Cigna continues to make impressive and innovative progress on the mobile front. As part of the company’s ongoing efforts to support medical professionals and patients with convenient and comforting mobile resources, this week the team at Cigna confirmed that HopeLab’s free cancer-fighting Re-Mission 2 online …   Read More

1264 0
1264 0

Cigna, HopeLab Turn to Mobile to Support Medical Professionals, PatientsAs our sister site mHealthWatch recently reported,  the team at Cigna continues to make impressive and innovative progress on the mobile front.

As part of the company’s ongoing efforts to support medical professionals and patients with convenient and comforting mobile resources, this week the team at Cigna confirmed that HopeLab’s free cancer-fighting Re-Mission 2 online games and the Re-Mission 2: Nanobot’s Revenge mobile app will be demonstrated this week at the Association of Pediatric Hematology/Oncology Nurses (APHON) 37th Annual Conference and Exhibit.

The event is scheduled to take place September 19-21, 2013 in Louisville, Kentucky.

Designed to help young cancer patients stick to their treatments, the games are free to play online and free to download for Android and iOS mobile devices.

As MHW covered earlier this month, Cigna and HopeLab previously announced a joint effort to promote the Re-Mission 2 online games and app to a global audience, including medical professionals and caregivers who support young cancer patients.

The annual APHON conference gathers more than 900 pediatric and adolescent and young adult (AYA) hematology/oncology nurses and other healthcare professionals to explore ways to enhance their practice.

“Technology and games offer new ways for medical professionals to support the health of young cancer patients,” said Scott Josephs, M.D., Cigna national medical officer. “Cigna is pleased to help raise visibility for HopeLab’s Re-Mission 2 games and the research behind them.”

In this article